Wayne Foster insider trades

Open-market stock purchases and sales by Wayne Foster, EVP, Chief Accounting Officer at Atea Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 30, 2018.

Recent trades

DateStockTradeValue
Jan 31, 2026AVIR Atea Pharmaceuticals, IncBought (not open market)—
Jan 31, 2026AVIR Atea Pharmaceuticals, IncSold (not open market)$51.4K
Jan 31, 2026AVIR Atea Pharmaceuticals, IncBought (not open market)—
Jan 31, 2026AVIR Atea Pharmaceuticals, IncBought (not open market)—
Jan 31, 2026AVIR Atea Pharmaceuticals, IncBought (not open market)—

Companies traded

  • AVIR Atea Pharmaceuticals, Inc: 1 sale, last Jan 31, 2026
  • MRSN Mersana Therapeutics, Inc: other filings, last Feb 2, 2018

Get free alerts when Wayne Foster files a new trade →